Literature DB >> 10702678

Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.

Y Pan1, S Kytölä, F Farnebo, N Wang, W O Lui, N Nupponen, J Isola, T Visakorpi, U S Bergerheim, C Larsson.   

Abstract

Human prostate cancer is characterized by multiple gross chromosome alterations involving several chromosome regions. However, the specific genes involved in the development of prostate tumors are still largely unknown. Here we have studied the chromosome composition of the three established prostate cancer cell lines, LNCaP, PC-3, and DU145, by spectral karyotyping (SKY). SKY analysis showed complex karyotypes for all three cell lines, with 87, 58/113, and 62 chromosomes, respectively. All cell lines were shown to carry structural alterations of chromosomes 1, 2, 4, 6, 10, 15, and 16; however, no recurrent breakpoints were detected. Compared to previously published findings on these cell lines using comparative genomic hybridization, SKY revealed several balanced translocations and pinpointed rearrangement breakpoints. The SKY analysis was validated by fluorescence in situ hybridization using chromosome-specific, as well as locus-specific, probes. Identification of chromosome alterations in these cell lines by SKY may prove to be helpful in attempts to clone the genes involved in prostate cancer tumorigenesis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  1999        PMID: 10702678     DOI: 10.1159/000015432

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  12 in total

1.  Evidence of chromosomal instability in prostate cancer determined by spectral karyotyping (SKY) and interphase fish analysis.

Authors:  B Beheshti; P C Park; J M Sweet; J Trachtenberg; M A Jewett; J A Squire
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Male germ cell-associated kinase is overexpressed in prostate cancer cells and causes mitotic defects via deregulation of APC/CCDH1.

Authors:  L-Y Wang; H-J Kung
Journal:  Oncogene       Date:  2011-10-10       Impact factor: 9.867

3.  Isolation of circulating tumor cells using a microvortex-generating herringbone-chip.

Authors:  Shannon L Stott; Chia-Hsien Hsu; Dina I Tsukrov; Min Yu; David T Miyamoto; Belinda A Waltman; S Michael Rothenberg; Ajay M Shah; Malgorzata E Smas; George K Korir; Frederick P Floyd; Anna J Gilman; Jenna B Lord; Daniel Winokur; Simeon Springer; Daniel Irimia; Sunitha Nagrath; Lecia V Sequist; Richard J Lee; Kurt J Isselbacher; Shyamala Maheswaran; Daniel A Haber; Mehmet Toner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-07       Impact factor: 11.205

4.  Upregulation of Cyclin B1 by miRNA and its implications in cancer.

Authors:  Vera Huang; Robert F Place; Victoria Portnoy; Ji Wang; Zhongxia Qi; Zhejun Jia; Angela Yu; Marc Shuman; Jingwei Yu; Long-Cheng Li
Journal:  Nucleic Acids Res       Date:  2011-11-03       Impact factor: 16.971

Review 5.  Prostate cancer between prognosis and adequate/proper therapy.

Authors:  T Grozescu; F Popa
Journal:  J Med Life       Date:  2017 Jan-Mar

6.  A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer.

Authors:  Jonathan F Anker; Hanlin Mok; Anum F Naseem; Praveen Thumbikat; Sarki A Abdulkadir
Journal:  J Vis Exp       Date:  2018-03-06       Impact factor: 1.355

7.  Authentication of M14 melanoma cell line proves misidentification of MDA-MB-435 breast cancer cell line.

Authors:  Christopher Korch; Erin M Hall; Wilhelm G Dirks; Margaret Ewing; Mark Faries; Marileila Varella-Garcia; Steven Robinson; Douglas Storts; Jacqueline A Turner; Ying Wang; Edward C Burnett; Lyn Healy; Douglas Kniss; Richard M Neve; Raymond W Nims; Yvonne A Reid; William A Robinson; Amanda Capes-Davis
Journal:  Int J Cancer       Date:  2017-10-10       Impact factor: 7.396

8.  Fate of the human Y chromosome linked genes and loci in prostate cancer cell lines DU145 and LNCaP.

Authors:  Sandeep Kumar Yadav; Anju Kumari; Sher Ali
Journal:  BMC Genomics       Date:  2013-05-11       Impact factor: 3.969

9.  Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines.

Authors:  Lien Spans; Christine Helsen; Liesbeth Clinckemalie; Thomas Van den Broeck; Stefan Prekovic; Steven Joniau; Evelyne Lerut; Frank Claessens
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.

Authors:  Oded Danziger; Ben Shai; Yosef Sabo; Eran Bacharach; Marcelo Ehrlich
Journal:  Oncotarget       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.